Intellia Therapeutics's total assets for Q3 2025 were $925.27M, an increase of 2.93% from the previous quarter. NTLA total liabilities were $176.85M for the fiscal quarter, a -3.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.